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Transcription factors control which information in a genome becomes transcribed to produce RNAs that function in the
biological systems of cells and organisms. Reliable and comprehensive information about transcription factors is invaluable
for large-scale network-based studies. However, existing transcription factor knowledge bases are still lacking in well-
documented functional information.
Here, we provide guidelines for a curation strategy, which constitutes a robust framework for using the controlled voca-
bularies defined by the Gene Ontology Consortium to annotate specific DNA binding transcription factors (DbTFs) based on
experimental evidence reported in literature. Our standardized protocol and workflow for annotating specific DNA bind-
ing RNA polymerase II transcription factors is designed to document high-quality and decisive evidence from valid experi-
mental methods. Within a collaborative biocuration effort involving the user community, we are now in the process of
exhaustively annotating the full repertoire of human, mouse and rat proteins that qualify as DbTFs in as much as they are
experimentally documented in the biomedical literature today. The completion of this task will significantly enrich Gene
Ontology-based information resources for the research community.
Database URL: www.tfcheckpoint.org
.............................................................................................................................................................................................................................................................................................
Introduction
Specific gene regulation mechanisms determine which part
of the genome becomes transcribed to provide the active
molecular parts of living organisms in various environmen-
tal conditions. Central in these mechanisms are multipro-
tein complexes present at the regulatory regions of genes
that determine the onset and rate of RNA synthesis by
regulating RNA polymerase activity (1, 2). These multipro-
tein complexes comprise general transcription factors,
general co-factors (3), RNA polymerase II (RNAP II) se-
quence-specific DNA binding transcription factors (DbTFs)
(4) and a large array of transcriptional regulators that
lack DNA-binding activity but exert their regulatory roles
through protein interaction with the aforementioned pro-
teins (which include co-activators, co-repressors, histone
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modifiers and chromatin remodeling proteins (1, 2).
General transcription factors bind to core-promoter DNA
where they constitute pre-initiation transcription complex-
es, in concert with general co-factors, whereas DbTFs bind
to gene-specific proximal and distal gene regulatory
regions. RNAP II, one of the three nuclear RNA polymerases
(RNAP I, II and III) involved in transcription of mammalian
genes, draws special attention in studies directed at gene
regulatory mechanisms, as it is responsible for transcribing
protein-coding genes as well as miRNA and other RNA
genes (5).
Owing to their selective binding within regulatory
regions of distinct genes, the DbTFs play decisive roles in
directing the assembly of the multiprotein transcription
machinery to a particular subset of genes. This assembly
can either be followed by immediate RNAP II-dependent
transcription or it can result in promoter-proximal pausing
of RNAP II that can subsequently be released into active
transcription triggered by either DbTFs or other mechan-
isms (1, 6, 7). DbTFs also play a central role in transcription
repression either by competing with activating DbTFs for
DNA binding or by recruiting transcriptional co-repressors
(2, 8). Through these functions, DbTFs link the phenotypical
state of the cell—reflected in abundance and activation
state of proteins in the transcriptional machinery—to the
decoding of regulatory information embedded within the
genome sequence. Thus, the DbTFs are a point of conver-
gence for mechanisms involved in upward causation, i.e.
the flow of information from genome to phenome (central
dogma), as well as in downward causation, which enables
the organism to respond to cues from the extrinsic and
intrinsic environment (9).
Current estimates suggest that the human genome con-
tains 1900 DbTF-coding genes (10). With the increasing
trend to pursue a systems-level understanding of gene
regulatory networks (11), it is of key importance to have
available genome-wide and accurate information concern-
ing DbTFs including their specific roles in transcription regu-
lation, their target genes (TGs) and their expression
patterns related to cell type and to developmental as well
as to normal- and pathophysiological processes. This need
for genome-wide information has sparked (among others)
the ENCODE project, an initiative to identify all functional
elements in the human genome sequence and the regula-
tory interactions between TFs and their transcription factor
binding sites (TFBS) (12). Thus, experimental data will con-
tinue to become available in ever-increasing volumes, and
subsequent comprehensive annotation of functional
aspects of DbTFs in public databases will be of high value
for ongoing and future gene regulatory studies.
The Gene Ontology (GO) provides a common vocabulary
for the functional description of genes and gene products
and consists of three sub-ontologies: Biological Process (BP),
Molecular Function (MF) and Cellular Component (13).
The Gene Ontology Consortium (GOC) provides high-qual-
ity classifications for types of transcription factors and cap-
tures the supporting evidence for the assignment of classes
to gene products. Recently (2010–2011), the GOC under-
took a major reorganization of the representation of tran-
scription factors within GO to bring this area up-to-date
with current knowledge, to incorporate some advances in
the ontological representation allowed in GO and to make
all of the transcription factor terms conform to the prin-
ciple that terms in the MF aspect of GO should represent
knowledge about the mechanism of action of that func-
tion, e.g. ‘DNA binding’, ‘RNA polymerase binding’ or ‘tran-
scription factor binding’.
The reorganization of the transcription factor MF terms
generated a more robust ontology structure by improving
both textual definitions and relationships between terms in
the ontology structure [(14); see also Supplementary
Material 1 for additional comments on background and
orientation for the reorganization].
For example, nucleic acid-binding transcription factors
must have nucleic acid-binding activity to function and
also must regulate transcription. Thus, the MF terms for
types of ‘nucleic acid binding transcription factor activity’
are required to have ‘has_part’ relationships to the appro-
priate MF terms for ‘nucleic acid binding’ [e.g. ‘sequence-
specific DNA binding RNA polymerase II transcription factor
activity’ (GO:0000981) has_part ‘RNA polymerase II regula-
tory region sequence-specific DNA binding’ (GO:0000977)]
(see Figure 1). Equally important, MF ‘transcription factor
activity’ terms [e.g. ‘sequence-specific DNA binding RNA
polymerase II transcription factor activity’ (GO:0000981)]
are also required to have ‘part_of’ relationships to appro-
priate BP terms for ‘regulation of transcription’ (e.g. ‘regu-
lation of transcription from RNA polymerase II promoter’
(GO:0006357)], as the overall biological objective of the
function of the molecule is to take part in regulating tran-
scription. These ‘part_of’ relationships between a specific
MF term and a BP term represent a previous advance in
the use of relationships within the GO structure to provide
more contextually-dependent MF terms, e.g. when the
same enzymatic activities are used in more than one pro-
cess. In the course of revising the transcription section of
GO, we incorporated these ‘part_of’ links from MF to BP
terms to provide more complete representation of the
‘transcription factor activity’ terms, which are located
within the MF aspect of GO. Examples of these ‘has_part’
and ‘part_of’ relationships for these MF terms are shown in
Figure 1. Retention of a generic ‘transcription factor activ-
ity’ does not make sense in the MF ontology because from a
MF viewpoint it is equivalent to an otherwise unknown MF
that regulates transcription. However, the BP term ‘tran-
scription, DNA dependent’ can be used to annotate all
gene products that regulate transcription, even when the
mechanism of action is not known.
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Today (GO database release on 16 February 2013), the
GOC provides annotations that allow for identification of
300 human, mouse and rat DbTFs, which is 15% of the
expected DbTFs (10). Only 200 of these are presently sup-
ported by experimental evidence, whereas 100 are anno-
tated with evidence based on computational prediction,
sequence and structure similarity or author statement
(GO database release on 16 February 2013). There are sev-
eral mammalian DbTF databases, including TFcat (15),
JASPAR (16) and TFe (17), that also hold experimentally
documented DbTF information based on cited scientific lit-
erature. However, these databases lack informative anno-
tations founded on ontologies and evidence codes (as
provided by the GOC), which are necessary for rigorous
computational reasoning and analysis.
The above findings suggest that, to date, no single com-
prehensive information resource for mammalian DbTFs
exists with the level of coverage and high-quality annota-
tion that is needed for genome-scale data analysis and in-
terpretation. The GOC has standard procedures for
annotating proteins, and their database is authoritative in
providing comprehensive annotations to the myriad of
tools that use GO information for data analysis. However,
the capacity of expert curators at the GOC is presently not
scaled for or focused for dedicated efforts to comprehen-
sively annotate one particular functional protein class.
Therefore, we have embarked on a collaborative effort
involving community users and GOC members to exhaust-
ively curate experimentally documented mammalian
DbTFs. Similar to other sub-domain annotation initiatives
(18, 19), our first aim was to develop specific guidelines
for curating experimentally documented DbTFs from litera-
ture. This included the assembly of a list of experimental
assays that would qualify to provide verifiable functional
evidence for genuine DbTFs. Here, we provide a detailed
report in the form of a comprehensive curation protocol,
based on which we are currently engaged in a focused
effort to curate all experimentally characterized DbTFs
from a collection of candidate proteins compiled from the
major TF information sources. A database providing
detailed information about TF information sources and
assembled DbTF documentation is available at www.
tfcheckpoint.org.
Creation of annotations for
sequence-specific DNA binding
RNAPII Transcription Factors
(DbTFs)
Our curation guidelines for high-quality annotation of
experimentally verified DbTFs are designed to capture the
essential functional capabilities of DbTFs and record pub-
lished evidence using rigorous semantics. In the following
sections, we describe fundamental functional characteris-
tics of a DbTF, how these characteristics can adequately
be described by GO terms and how these terms and
evidence codes can be asserted based on experimental
work reported in literature. The assembled procedure
facilitates a precise representation of DbTF functional attri-
butes using the standard GOC-defined gene-association file
format (GAF2.0; http://www.geneontology.org/GO.format.
gaf-2_0.shtml) and the PSI-MI data exchange format used
for recording interaction data (20). A detailed DbTF anno-
tation guideline document is provided in Supplementary
Material 2.
Criteria that qualify a DbTF
A DbTF is a DNA binding transcription factor that binds to a
specific DNA sequence and regulates the transcription of
the associated gene. The specific DNA sequences bound
by DbTFs are termed TFBS, and for RNAPII these are located
in gene regulatory regions either upstream and proximal to
the core promoter, or in more distal upstream or down-
stream enhancer regions. Once a DbTF recognizes a TFBS,
it may recruit other accessory factors or RNAPII, or it may
interfere with binding of other regulatory proteins to regu-
late the expression of the TG. This means that a DbTF must
exhibit both DNA-binding and transcription regulation cap-
acity. Therefore, the minimum criteria to qualify a protein
as DbTF for RNAPII are that it (i) binds to specific DNA
sequences in gene regulatory regions and (ii) is involved
in RNAPII-dependent regulation of transcription.
It is evident that to capture these functional aspects
accurately and efficiently, the specific GO terms that sub-
stantiate these assertions need to be precisely defined.
These GO terms must address both ‘sequence-specific
DNA binding’ and ‘transcription regulation’ capabilities
accurately. In the following sections, we provide a detailed
reasoning behind the selection of specific GO terms of dif-
ferent granularity as well as assignment of GO evidence
codes and experimental assays that are considered
adequate and necessary for creating a DbTF annotation.
GO terms used for DbTF annotation
Specific DNA binding. To capture the capability of a
protein to bind to specific DNA sequences, a GO MF term
that describes ‘sequence-specific DNA binding’ (e.g.
GO:0043565 ‘sequence-specific DNA binding’) should be
used. GO:0000976 ‘transcription regulatory region se-
quence-specific DNA binding’ should be used when it is
not possible to identify information stating that the regu-
latory region containing the DNA sequence specifically
bound by the DbTF is part of a gene regulated by RNAP
II. Where a gene is known to be transcribed by RNAP II, a
more specific term (GO:0000977 ‘RNA polymerase II regula-
tory region sequence-specific DNA binding’) may be
applied. If information exists that indicates whether the
.............................................................................................................................................................................................................................................................................................
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protein binds the proximal or distal regulatory regions, this
may be indicated by use of either of the terms describing
the location of binding (GO:0000978 ‘RNA polymerase
II proximal region sequence-specific DNA binding’ or
GO:0000980 ‘RNA polymerase II distal enhancer sequence-
specific DNA binding’) (Figure 1A, terms shaded yellow).
Transcription regulation. The involvement of a
protein in transcription regulation is well captured by the
GO BP terms GO:0006357 (regulation of transcription
from RNAP II promoter) or any of its children that
specify whether the protein is involved in positive or
negative regulation of transcription (Figure 1A, terms
shaded blue).
Sequence-specific DNA binding RNAP II transcrip-
tion factor activity. The goal of this curation project is
to assign a sequence-specific DbTF activity term, i.e.
GO:0000981 (sequence-specific DNA binding RNAP II tran-
scription factor activity) or one of its children to appropri-
ate DbTFs (Figure 1A, terms shaded green). As indicated
above, this requires that the composite functional aspects
of DbTF proteins—specific DNA binding and transcription
regulation— must each be represented by their proper MF
and BP GO terms. These different aspects of DbTF activity—
specific DNA binding and involvement in transcriptional
regulation—are typically demonstrated in different experi-
ments, sometimes not even presented in the same paper, so
the annotations to specific DNA binding (MF) and transcrip-
tional regulation (BP) terms are made separately, and only
when both are assigned (each in their inherent logic of the
GO-structure) can they be combined to infer DbTF activity
MF terms (Table 1).
The child terms of ‘GO: 0000981’ are used to delineate
whether the TF exerts its activity by binding to the
promoter proximal region or the distal enhancer, i.e.
‘GO:0000982 (RNAP II core promoter proximal region
sequence-specific DbTF activity)’ or ‘GO:0003705
(sequence-specific distal enhancer binding RNAP II tran-
scription factor activity)’, and whether the result of binding
is positive or negative regulation of TG transcription, e.g.
‘GO:0001077 (RNAP II core promoter proximal region se-
quence-specific DbTF activity involved in positive regulation
of transcription)’ and ‘GO:0001205 (RNAP II distal enhancer
sequence-specific DbTF activity involved in positive regula-
tion of transcription)’. Genes that have been shown to have
both positive and negative regulatory roles should be
annotated with both the positive and negative regulation
terms as appropriate.
TF binding and TF binding TF activity. Transcriptional
regulation mechanisms are complex. Usually many TFs work
together in concert to regulate transcription. In instances
where the activity of a TF is reported to be dependent on
interaction with another protein or multi-subunit complex,
the protein–protein interaction (PPI) is annotated using
‘transcription factor binding’ MF GO terms as shown in
Figure 1B (terms shaded yellow). Furthermore, a different
set of ‘transcription factor activity’ terms, i.e. ‘GO:0001076
(RNAP II transcription factor binding transcription factor
activity)’ or any of its children, is chosen to reflect the fact
that the activity is dependent on binding to another TF
(Figure 1B, terms shaded green).
Once TF binding and transcription regulation are each
annotated individually, the GO structure allows for the
generation of TF binding TF activity annotations by combin-
ing the separate annotations (Table 1).
When the functional unit of a TF is a complex
In instances where the complex is a homodimer or higher
order multimer of the same protein, there are no special
annotation issues, as all of the activities demonstrated are
properties of the same gene product. However, when the
functional unit is a heterodimer or other multisubunit com-
plex, then there are some additional considerations for
annotation.
The ‘contributes_to’ qualifier is specifically intended for
the annotation of functions that occur in the context of
complexes, rather than being an activity of a single subunit
within the complex. In the case of a heterodimer, there are
times where one of the two proteins does not bind DNA on
its own. However, in some cases, a subunit that does not
bind DNA independently can be shown to contribute to the
sequence specificity of binding when present within a het-
erodimer. In this situation, the subunit that does not bind
DNA alone could be annotated to appropriate ‘sequence-
specific DNA binding’ terms (Figure 1A, terms shaded
yellow) using the qualifier ‘contributes_to’ to indicate
that it contributes to the DNA binding of the heterodimer.
More generally, the ‘contributes_to’ qualifier can be used
in conjunction with any MF term, including the ‘transcrip-
tion factor activity’ terms, to indicate that it contributes to
that function within the context of a complex, even though
it does not possess that activity independently. In contrast,
in a multisubunit TF where the DNA binding activity is
known to be confined to one or more specific subunits,
other subunits should not be annotated to a ‘specific
DNA binding’ term at all.
For any subunit within a TF complex, it is appropriate
to annotate all appropriate GO terms for which that
function has been experimentally shown, either individu-
ally or as part of the complex indicated with the
‘contributes_to’ qualifier. Thus, in some cases, a given pro-
tein may be annotated both with a ‘sequence-specific DNA
binding RNAP II transcription factor activity’ term as well as
with a ‘TF binding RNAP II transcription factor activity’
term.
.............................................................................................................................................................................................................................................................................................
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Evidence codes and experimental assays
In accordance with the overall guidelines for GO annota-
tions, each DbTF annotation must be qualified with an
evidence code indicating how the annotation is supported
by experimental evidence (http://www.geneontology.org/
GO.evidence.shtml). The DbTF curation guidelines pre-
sented in the current work use one of the following GO
evidence codes: Inferred from Direct Assay (IDA), Inferred
from Physical Interaction (IPI), Inferred from Mutant
Phenotype (IMP) or Inferred by Curator (IC).
When a single scientific paper comprises all experimental
evidence necessary to support each of the annotations for
‘DNA- or TF-binding’ and ‘Transcription regulation’, the evi-
dence codes for these two annotations are transferred to
the composite DbTF annotation to a MF ‘transcription
factor activity’ term (see Table 2). However, when the
two different types of annotations (‘DNA’ or ‘TF-binding’
and ‘transcription regulation’) for a given TF cannot be
generated from one single paper, the evidence code IC
is used along with the GOC-generated reference,
Table 1. Inference of transcription factor activity terms from DNA/TF binding and transcription regulation terms
Binding terms 
(MF)
Transcripon regulaon terms (BP) 
GO:0006357  
regulaon of transcripon 
from RNA polymerase II 
promoter 
GO:0045944  
posive regulaon of 
transcripon from RNA 
polymerase II promoter 
GO:0000122  
negave regulaon of 
transcripon from RNA 
polymerase II promoter 
GO:0043565 
sequence-speciﬁc DNA 
binding 
GO: 0000981 
sequence-speciﬁc DNA binding 
RNA polymerase II 
transcripon factor acvity 
GO:0001228
RNA polymerase II transcripon 
regulatory region sequence-
speciﬁc DNA binding 
transcripon factor acvity 
involved in posive regulaon of 
transcripon 
GO:0001227
RNA polymerase II transcripon 
regulatory region sequence-
speciﬁc DNA binding 
transcripon factor acvity 
involved in negave regulaon of 
transcripon 
GO:0000976 
transcripon regulatory 
region sequence-speciﬁc 
DNA binding 
GO:0000977  
RNA polymerase II 
regulatory region 
sequence-speciﬁc DNA 
binding 
GO:0000978  
RNA polymerase II core 
promoter proximal 
region sequence-speciﬁc 
DNA binding 
GO:0000982
RNA polymerase II core 
promoter proximal region 
sequence-speciﬁc DNA binding 
transcripon factor acvity 
GO:0001077
RNA polymerase II core promoter 
proximal region sequence-
speciﬁc DNA binding 
transcripon factor acvity 
involved in posive regulaon of 
transcripon 
GO:0001078
RNA polymerase II core promoter 
proximal region sequence-
speciﬁc DNA binding 
transcripon factor acvity 
involved in negave regulaon of 
transcripon 
GO:0000980  
RNA polymerase II distal 
enhancer sequence-
speciﬁc DNA binding 
GO:0003705
sequence-speciﬁc distal 
enhancer binding RNA 
polymerase II transcripon 
factor acvity 
GO:0001205
RNA polymerase II distal 
enhancer sequence-speciﬁc DNA 
binding transcripon factor 
acvity involved in posive 
regulaon of transcripon 
GO:0001206 
RNA polymerase II distal 
enhancer sequence-speciﬁc DNA 
binding transcripon factor 
acvity involved in negave 
regulaon of transcripon 
GO: 0008134  
Transcripon factor 
binding 
GO: 0001076 
RNA polymerase II 
transcripon factor binding 
transcripon factor acvity 
GO:0001190 
RNA polymerase II transcripon 
factor binding transcripon 
factor acvity involved in posive 
regulaon of transcripon 
GO:0001191 
RNA polymerase II transcripon 
factor binding transcripon 
factor acvity involved in 
negave regulaon of 
transcripon 
GO: 0001085 
RNA polymerase II 
transcripon factor 
binding 
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Each transcription factor activity term (green) is determined by the composite annotation of the corresponding DNA binding or TF
binding term (yellow) and a transcription regulation term (blue).
.............................................................................................................................................................................................................................................................................................
Page 6 of 12
Original article Database, Vol. 2013, Article ID bat062, doi:10.1093/database/bat062
.............................................................................................................................................................................................................................................................................................
 at N
orges Teknisk-N
aturvitenskapelige U
niversitet on N
ovem
ber 29, 2013
http://database.oxfordjournals.org/
D
ow
nloaded from
 
GO_REF:0000036 (http://www.geneontology.org/cgi-bin/
references.cgi#GO_REF:0000036). The IC code, which
requires the use of the two GO IDs for the appropriate
‘binding’ and ‘transcription regulation’ terms, indicates
that GO annotations based on evidence from two different
sources have been combined by a curator to infer the
appropriate transcription factor activity term.
To provide for a uniform standard for evaluation of
experimental evidence for DbTF annotations, we surveyed
several relevant resources defining experimental assays
that can document TF function, including ORegAnno (21),
TRRD (22), RegulonDB (23) and the PSI-MI controlled vo-
cabulary for molecular interactions (20).
In the following sections, we have compiled sets of se-
lected experimental assays that we deem to be most relevant
for annotation of DNA binding, TF binding and transcription
regulation. PSI-MI-unique identifiers are given wherever
they exist. Augmentation of the PSI-MI vocabulary to span
a larger repertoire of TF-defining experiments is ongoing.
Specific DNA binding. Experimental data documenting
specific DNA binding are obtained from experiments that
show in vitro binding of a TF to specific DNA sequences
present in either cloned TG regulatory regions (proximal
promoter and/or distal enhancer) or in synthetic DNA
sequences representing canonical TF binding sites or spe-
cific TG regulatory regions (see Table 3). We have chosen
not to rely on assays measuring in vivo TF–DNA interaction
(e.g. the Chromatin ImmunoPrecipitation assay) because it
is not possible to ascertain in these assays that the TF in
question actually binds directly to DNA, or whether some
other component in the in vivo system mediates the
TF–DNA association.
The in vitro assay that has been most frequently used for
documenting sequence-specific binding of TF is the
Electrophoretic Mobility Shift Assay (EMSA) (24). The most
common variants of this assay present the TF in the form of:
(i) nuclear extract from native tissue or cells
(ii) nuclear extracts from cells or tissue with ectopic
expression of a TF
(iii) purified TF (in vitro translated or purified from cell
extract)
(iv) nuclear extract from cells with ectopic expression of a
mutated TF
(v) purified mutated TF (in vitro translated or purified
from cell extract).
When the TF is presented in any of the variants (ii–v), the
EMSA qualifies for annotation of a GO term for ‘specific
DNA binding’. In the case where the TF is presented as a
nuclear extract from native cells or tissue (i), we require
that the specific TF is identified with an additional experi-
mental approach. This may involve specific competition
experiments demonstrating that the EMSA gel shift is not
abolished by competition with an unlabeled DNA probe
with a point mutation in a known TFBS for this specific
TF, whereas competition with unlabeled DNA probe
containing the wild-type TFBS does abolish the gel shift.
Also, the use of a TF-specific antibody, i.e. EMSA supershift,
will increase confidence in EMSA assays with nuclear ex-
tracts from native tissue or cells; however, these assays
must be interpreted with caution, as the DNA–protein com-
plex may be shifted even though a different protein than
the one recognized by the antibody provides for the DNA-
binding part in the complex. If no additional experimental
verification of the TF is reported, nuclear extract-based
EMSAs of type (i) do not suffice to qualify DNA binding
properties of a TF, and the experiment needs to be
dismissed.
Similarly, the other assays listed in Table 3 must have
been performed in a manner that provides for identifica-
tion of the specific TF tested and to assess specific inter-
action between this TF and a specified DNA probe. For
MI:0114 X-ray crystallography, to qualify as experimental
evidence of a TFs DNA binding, it is required that the pro-
tein is co-crystallized with a DNA sequence that represents
either a canonical TFBS or an authentic gene regulatory
region.
Transcription regulation. The ‘transcription regula-
tion’ terms need support from assays that document modu-
lation of transcriptional process in response to TF action.
These assays mainly fall into two groups: either reporter
gene assays measuring the transcriptional regulatory
effect of a TF on a regulatory region cloned upstream of
a reporter gene (e.g. luciferase, beta-galactosidase or chlor-
amphenicol acetyltransferase), or measurement of expres-
sion levels of a TG mRNA (see Table 4). Within each of the
assays, a variety of experimental strategies can allow for
the identification of the specific TF [e.g. ‘knock in’ (ectopic
expression) and/or ‘knock down’]. Furthermore, the gene
regulatory region can be presented and assessed in differ-
ent ways in the reporter gene assays (e.g. ‘canonical TFBS’
or ‘authentic TG promoter/enhancer’) and different
Table 2. Evidence code table
DNA binding/
TF binding
Transcription
regulation
TF activity
IDA IDA IDA/ICa
IMP IMP IMP/ICa
IDA IMP IDA, IMP/ICa
IMP IDA IMP, IDA/ICa
IPIb IDA IPIb, IDA/ ICa
ICa if evidence for ‘DNA binding / TF binding’ and ‘transcription
regulation’ comes from two different papers.
IPIb applicable only for TF binding terms.
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methods used to assay mRNA expression levels of specific
TGs. The combinations of different modes of TF and TG
detection together define the GO evidence codes to be
used (Table 4).
Although the experimental assays depicted in Table 4
are most often carried out by transfecting expression and
reporter plasmids into cell line model systems, transcription
regulation annotations can also be supported by whole or-
ganism experiments, e.g. knock out mutations or
RNAi knock down strategies. However, as such experiments
do not by themselves prove a role in regulation of tran-
scription, such annotations must be made with caution
and will depend on a strict awareness of additional
information such as the concomitant documentation of
specific binding by the protein in question, to regulatory
regions of an RNAP II regulated gene (e.g. by Chromatin
ImmunoPrecipitation assay analysis).
TF binding. ‘TF binding’ specific terms are based on any
assay that provides evidence for PPIs. Table 5 lists experi-
mental assays and evidence codes that are eligible for TF
binding specific terms. Currently, we are only making these
annotations from ‘small scale’ papers that we come across
for proteins that are also DbTFs or for proteins with se-
quence similarity to DbTFs but which do not appear to
bind DNA. Any future extension of this work to use high
throughput PPI data would need to carefully consider what
standards should be applied to minimize the effect of the
high level of false-positives in high throughput PPI data.
Annotating TGs
An obvious important biological property of a TF lies in the
particular TGs that it regulates. Proper recording of this
information is of key importance for the building of gene
Table 3. Assays documenting specific DNA binding
Experimental assays Variants Evidence code PSI-MI
code
EMSA Nuclear extract from native tissue or cells No evidence MI:0413
Nuclear extracts from cells or tissue with
ectopic expression of a TF
IDA MI:0413
Purified TF (in vitro translated or purified
from cell extract)
IDA MI:0413
Nuclear extract from cells with ectopic
expression of a mutated TF
IMP MI:0413
Purified mutated TF (in vitro translated
or purified from cell extract
IMP MI:0413
Electrophoretic mobility supershift assay
(EMSA supershift)
Nuclear extract from native tissue or cells IDA MI:0412
Nuclear extracts from cells or tissue with
ectopic expression of a TF
IDA MI:0412
Purified TF (in vitro translated or purified
from cell extract)
IDA MI:0412
Nuclear extract from cells with ectopic
expression of a mutated TF
IMP MI:0412
Purified mutated TF (in vitro translated
or purified from cell extract)
IMP MI:0412
Footprinting IDA MI:0417
DNase I footprinting (DNA footprint) IDA MI:0606
Methylation interference assay (MIC) IDA MI:1189
Ultraviolet (UV) footprinting (UV-footprint) IDA MI:1191
Dimethylsulphate footprinting (DMS-footprint) IDA MI:0603
Hydroxy radical footprinting (Hydroxy-footprint) IDA MI:1190
Potassium permanganate footprinting (KMnO4-footprint) IDA MI:0604
Affinity chromatography technology IDA MI:0004
Pull down IDA MI:0096
Southwestern blot assay (SW-blot) IDA
In vitro evolution of nucleic acids (SELEX) IDA MI:0657
X-ray crystallography IDA MI:0114
The experimental assays are denoted with their standard nomenclature in PSI-MI; for the detailed description please see: http://www.ebi.
ac.uk/ontologylookup/browse.do?ontName=MI. For Southwestern blot assay, see: http://www.nlm.nih.gov/mesh/.
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regulatory networks. In studies of DbTF functionality, often
one or several specific TGs will be identified and experimen-
tally documented. The GOC has introduced an Annotation
Extension field to capture additional information that
provides more biological context to the GO annotation
(GAF 2.0, http://www.geneontology.org/GO.format.gaf-2_
0.shtml). This field can be used to record information
regarding specific TGs regulated by the TF that is being
annotated. The TG is recorded in the Annotation
Extension field for the BP transcription regulation GO
term using the ‘has_regulation_target’ relationship com-
bined with the gene identifier(s) for the TG(s).
Work flow of annotation
The annotation workflow is depicted in Figure 2. An anno-
tation effort typically starts with one of the scientific papers
suggested in databases such as TFCat and JASPAR to docu-
ment a candidate DbTF, or by searching for adequate lit-
erature in one of the following resources: UniProt (http://
www.uniprot.org/), NCBI’s Entrez Gene (25), iHOP (26),
Gene Cards (27) or NCBI’s PubMed (http://www.ncbi.nlm.
nih.gov/pubmed/). Each scientific paper is first checked for
information providing correct identification of species
origin of the TF studied. Because we are focusing on
DbTFs from human, mouse and rat studies, only papers
allowing identification of a DbTF from one of these species
will proceed to further curation. Thus, a number of papers
that fail to clearly identify the species of the gene(s) used in
their construct(s) have to be omitted from the curation pro-
cess. Then, the paper is searched for adequate experimental
evidence to support one or several DbTF annotations. If
either TF species origin or sufficient experimental evidence
is not identifiable, the curator returns to the scientific lit-
erature corpus to search for other suitable papers. When
both criteria are fulfilled, the individual GO annotations
(i.e. specific DNA binding and/or TF binding and transcrip-
tion regulation) are assigned together with a supporting
evidence code. Finally, the composite TF activity MF GO
term(s) is inferred. TF annotation data are submitted to
UniProt-GOA in the form of a gene association file
(GAF2.0; http://www.geneontology.org/GO.format.gaf-2_
0.shtml) and will subsequently appear in the GOC database
via tools such as AmiGO (http://amigo.geneontology.org/)
and QuickGO (http://www.ebi.ac.uk/QuickGO/; Figure 3).
DISCUSSION
Benefits of a focused annotation project
A comprehensive resource of high-quality annotations of
TFs is of high value both for small-scale experiments
where it is important to select an optimal subset of relevant
TFs and for genome-scale studies. In the latter case, access
Table 4. Reporter gene-based assays variants documenting transcription regulation
       TF 
idenﬁcaon 
Transcripon  regulaon assays
reporter gene assay TG expression assay 
canonic
al TFBS 
authenc 
TG 
promoter 
authenc TG 
promoter with 
TFBS point 
mutaon 
authenc TG 
promoter with 
deleon 
mutaons 
primer 
speciﬁc PCR 
(e.g. RT-PCR, 
qRT-PCR) 
northern 
blot 
Ribonuclease
protecon 
assay 
wt TF 
overexpression 
IDA IDA IDA IDA IDA IDA IDA 
mut TF 
overexpression 
IMP IMP IMP IMP IMP IMP IMP 
TF knock down 
(RNAi/ansense 
RNA) 
IMP IMP IMP IMP IMP IMP IMP 
This table is a decision matrix for selecting GO evidence codes based on the method used for TF identification (purple) and transcription
regulation (green). wt = wild type, mut = mutated.
Table 5. Assays documenting TF binding
Assays Evidence code PSI-MI code
2-Hybrid interactions IPI MI:0018
Co-purification IPI, IDA MI:0004
Co-immunoprecipitation IPI, IDA MI:0019
The experimental assays are denoted with their standard nomen-
clature in PSI-MI; for the detailed description please see:
http://www.ebi.ac.uk/ontologylookup/browse.do?ontName=MI.
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to extensive background knowledge for TFs is essential to
infer gene regulatory networks (28) or to design experi-
ments to characterize this group of proteins as a functional
class in a system-wide approach (29, 30).
Compilation and in-depth analysis of available informa-
tion on transcription factors indicate that >800 mammalian
DbTFs are experimentally documented in the scientific lit-
erature (www.tfcheckpoint.org). The current work aims to
provide the foundation to curate this source of information
and to record adequate GO annotations in compliance with
the standards defined here. Currently (GO database release
on 16 February 2013), only 202 human, mouse and rat pro-
teins are annotated as DbTFs with ‘GO:0000981 sequence-
specific DNA binding RNA polymerase II transcription factor
activity’ (or any of its child terms) supported by experimen-
tal evidence, meaning that some 600 DbTFs still need to be
processed. We aim to complete this task before the end of
2013. Even though the number of curators involved is small,
the efficiency of this focused annotation project is high, as
the number of different GO terms and evidence codes is
limited and well defined, thus allowing each curator to pro-
cess a relatively high number of scientific papers (typically
five papers or more per working day).
Added value of rigorous classification of experimental
assay requirements for the annotations
The catalogue of experimental assays that qualify for sup-
porting TF annotations presented here is assembled based
on the extensive TF annotation experience in the collabor-
ating organizations. This aspect of the annotation proced-
ure improves the quality of the GO annotations, as it
provides a uniform standard for interpretation of evidence
strength in published experimental work. As some of the
assays presently are not adequately covered by PSI-MI
vocabulary (20), a part of our efforts has been directed to
collaborate with the PSI-MI consortium to develop add-
itional PSI-MI terms. The proper documentation of experi-
mental evidence for each TF annotation will enable us to
work toward submitting annotated data to the IntAct data-
base (31). Moreover, we plan to make the experimental
assay details for the TF annotations available to users via
our TF database (http://www.tfcheckpoint.org/). This will
enable users to select subsets of TFs based on the specific
experimental methods used to characterize them.
Concluding remarks
Metadata are rarely presented in biomedical publications
using formalized knowledge representation. This often
makes it difficult for a curator to extract accurate informa-
tion for ontology- or structured vocabulary-annotation
from natural language used in the literature. The GOC pro-
vides guidelines for the curation of gene products informa-
tion from scientific publications and procedures for
identification of the type of evidence that supports the
curated information. Because of these standardized con-
ventions, literature-curated data in the GO database are
deemed to be of high utility and quality. In the present
work, we have established a comprehensive and specific
curation procedure for TFs of RNAP II, which, similar to
other data standardization initiatives, provides details on
the requirements to properly record an experimentally ver-
ified DbTF.
Selected paper
Species
YES
NO
YES
Experimental 
     evidence 
NO
Gene Ontology 
Gene Ontology 
        terms
DNA binding
terms (MF)  terms (BP)
TF-binding
terms (MF)
  DNA binding   TF binding
Figure 2. Sequence-specific DNA binding TF (DbTF) curation
workflow. This workflow represents the step-by-step proced-
ure for curating experimentally verified mammalian DbTFs
from scientific publications. Selection of scientific publication
from the literature corpus is the starting point of the curation
procedure. From each relevant publication, DbTF-specific
GO-terms are annotated and recorded.
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The GOC is centrally involved in efforts to provide
annotation guidelines for particular protein functional
categories. However, the elaboration of procedures for spe-
cific tasks like the curation of distinct functional categories
of proteins, or of BP subdomains, is enhanced when experts
in the respective fields are involved in the curation process.
Moreover, the active participation from domain experts is
greatly facilitated by generating detailed curation guide-
lines as vehicles for productive interactions. With the tran-
scription factor curation effort presented here, we wish to
provide not only a greater number of high-quality annota-
tions for DbTFs and their TGs across three mammalian
species, but also to exemplify the constructive use of
detailed guidelines to facilitate collaborative biocuration
efforts across institutions.
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